Jefferies Group’s Alimera Sciences ALIM Stock Holding History

Jefferies Group’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-3,440	Closed	-$280K	–	2410
2014 Q3	$280K	Buy	+3,440	New	+$294K	﹤0.01%	1648

Other funds holding ALIM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Scale Management Foster City, California $359M AUM

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jefferies Group's ALIM Position: Q1 2016 in Review

Jefferies Group sold out of Alimera Sciences (ALIM) in Q1 2016, closing a stake of 32,479 shares — an estimated $1.18M sold.

Jefferies Group first reported a position in ALIM in Q3 2015 and held it in 2 quarters. The position peaked at $1.18M in Q4 2015. 54 funds tracked by Wall St. Rank hold ALIM as of Q1 2016.

Jefferies Group reported no remaining Alimera Sciences position as of Q1 2016 after selling out during the quarter.
Jefferies Group sold 32,479 Alimera Sciences shares in Q1 2016, an estimated $1.18M.
Jefferies Group first reported a position in Alimera Sciences in Q3 2015 and held it in 2 quarters.
Jefferies Group's Alimera Sciences position peaked at $1.18M in Q4 2015.
54 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2016.

Based on Jefferies Group's 13F filing for Q1 2016, filed 11 May 2016.